Skip to main content
. 2019 Mar 7;10:169. doi: 10.3389/fphar.2019.00169

Figure 8.

Figure 8

Concentration of selected lipid mediators measured in plasma from patients with (sepsis, n = 18) and without (control, n = 10) septic shock. Patients with septic shock are divided into survivors (>28 days, n = 5) and non-survivors (n = 13). Shown are concentrations in nM as individual values of (A) ARA derived PGE2, 5-lipoxygenation products and SPM pathway marker as well as SPMs derived from (B) ARA, (C) EPA, and (D) DHA. Median is given, if >50% of the samples are >LLOQ. The LLOQ is indicated as dotted line.